NFC
LLY icon

Northeast Financial Consultants’s Eli Lilly LLY Stock Holding History

Northeast Financial Consultants’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$8.33M Buy
10,689
+132
+1% +$103K 0.34% 45
2025
Q1 		$8.72M Buy
10,557
+601
+6% +$500K 0.39% 40
2024
Q4 		$7.69M Buy
9,956
+24
+0.2% +$19.9K 0.32% 47
2024
Q3 		$8.8M Buy
9,932
+97
+1% +$87.2K 0.38% 41
2024
Q2 		$8.9M Buy
9,835
+56
+0.6% +$44.8K 0.41% 38
2024
Q1 		$7.61M Buy
9,779
+3,662
+60% +$2.61M 0.37% 45
2023
Q4 		$3.57M Buy
6,117
+1,241
+25% +$724K 0.2% 72
2023
Q3 		$2.62M Buy
4,876
+365
+8% +$188K 0.16% 86
2023
Q2 		$2.12M Sell
4,511
-31,343
-87% -$13.1M 0.13% 97
2023
Q1 		$12.3M Buy
35,854
+13
+0% +$4.38K 0.79% 25
2022
Q4 		$13.1M Buy
35,841
+523
+1% +$185K 0.89% 25
2022
Q3 		$11.4M Sell
35,318
-683
-2% -$216K 0.84% 25
2022
Q2 		$11.7M Buy
36,001
+1,310
+4% +$393K 0.81% 24
2022
Q1 		$9.93M Buy
34,691
+57
+0.2% +$14.7K 0.58% 34
2021
Q4 		$9.57M Hold
34,634
– – 0.58% 33
2021
Q3 		$8M Buy
34,634
+46
+0.1% +$11.4K 0.53% 35
2021
Q2 		$7.94M Buy
34,588
+200
+0.6% +$40.2K 0.53% 37
2021
Q1 		$6.42M Hold
34,388
– – 0.49% 41
2020
Q4 		$5.81M Hold
34,388
– – 0.48% 37
2020
Q3 		$5.09M Hold
34,388
– – 0.46% 37
2020
Q2 		$5.65M Hold
34,388
– – 0.54% 35
2020
Q1 		$4.77M Hold
34,388
– – 0.54% 36
2019
Q4 		$4.52M Hold
34,388
– – 0.4% 52
2019
Q3 		$3.85M Hold
34,388
– – 0.39% 56
2019
Q2 		$3.81M Sell
34,388
-100
-0.3% -$11.8K 0.39% 48
2019
Q1 		$4.47M Sell
34,488
-1,490
-4% -$181K 0.5% 39
2018
Q4 		$4.16M Buy
+35,978
New +$4.02M 0.58% 38

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northeast Financial Consultants's LLY Position: Q2 2025 in Review

Northeast Financial Consultants increased its Eli Lilly (LLY) stake by 1.3% in Q2 2025, buying an estimated $103K and bringing the position to 10,689 shares worth $8.33M. The position accounts for 0.34% of the portfolio, ranked #45.

Northeast Financial Consultants first reported a position in LLY in Q4 2018 and has held it in 27 quarters since. The position peaked at $13.1M in Q4 2022. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Northeast Financial Consultants held 10,689 shares of Eli Lilly worth $8.33M as of Q2 2025.
  • Northeast Financial Consultants bought 132 Eli Lilly shares in Q2 2025, an estimated $103K.
  • Eli Lilly made up 0.34% of Northeast Financial Consultants's portfolio in Q2 2025, its #45 holding.
  • Northeast Financial Consultants first reported a position in Eli Lilly in Q4 2018 and has held it in 27 quarters since.
  • Northeast Financial Consultants's Eli Lilly position peaked at $13.1M in Q4 2022.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Northeast Financial Consultants's 13F filing for Q2 2025, filed 15 Aug 2025.